ACM
VIR icon

ADAR1 Capital Management’s Vir Biotechnology VIR Stock Holding History

ADAR1 Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.6M Buy
+2,744,714
New +$21.9M 1.48% 14
2025
Q3 		– Sell
-250,000
Closed -$1.26M – 267
2025
Q2 		$1.26M Hold
250,000
– – 0.2% 73
2025
Q1 		$1.62M Buy
250,000
+185,933
+290% +$1.65M 0.31% 64
2024
Q4 		$470K Sell
64,067
-255,118
-80% -$2.01M 0.1% 113
2024
Q3 		$2.39M Buy
319,185
+209,185
+190% +$1.82M 0.4% 45
2024
Q2 		$979K Buy
+110,000
New +$1.05M 0.2% 66

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return